; and (ii) assures unbiased review of the highest scientific standards by qualified individuals with no interest in the outcome of the review. (3) Life-threatening condition defined For purposes of this subsection, the term life-threatening condition means any disease or condition from which the likelihood of death is probable unless the course of the disease or condition is interrupted. (4) Coverage determination requirements A determination with respect to coverage under subsection (a)(29) for an individual participating in a qualifying clinical trial— (A) shall be expedited and completed within 48 hours; (B) shall be made without limitation on the geographic location or network affiliation of the health care provider treating such individual or the principal investigator of the qualifying clinical trial; (C) shall be based solely on attestation regarding the appropriateness of the qualifying clinical trial by the health care provider and principal investigator described in subparagraph (B), which shall be made using a streamlined, uniform form developed for national use by the Secretary and that includes the option to reference information regarding the qualifying clinical trial that is publicly available on a website maintained by the Secretary, such as clinicaltrials.gov (or a successor website)